Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Evan Harwin currently holds 2,747,866 shares of Dianthus Therapeutics, Inc. /DE/ (DNTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Evan Harwin has been a net buyer of DNTH stock. They have purchased $29.7M and sold $0 worth of shares.
Peter Evan Harwin's most recent insider trade was on Dec 4, 2025, when they purchased 1,360,000 shares at $13.41 per share.
Peter Evan Harwin serves as Executive at Dianthus Therapeutics, Inc. /DE/ (DNTH). They have executed 28 insider transactions totaling $29.7M over their tenure at the company.
Peter Evan Harwin holds the position of Executive at Dianthus Therapeutics, Inc. /DE/, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Peter Evan Harwin has shown a buying trading pattern, with $29.7M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Peter Evan Harwin was on Dec 4, 2025, when they purchased $18.2M worth of CBIO shares. This transaction involved 1,360,000 shares at $13.41 per share.
Peter Evan Harwin currently owns 2,747,866 shares of Dianthus Therapeutics, Inc. /DE/ (DNTH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Evan Harwin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Evan Harwin has 28 Form 4 filings on record as an insider at Dianthus Therapeutics, Inc. /DE/.
Set alerts for Peter Evan Harwin and 40,000+ other insiders.